Viridos - formerly Synthetic Genomics

Viridos(formerly Synthetic Genomics, Inc) is a privately held biotechnology company harnessing the power of photosynthesis.

[ExxonMobil @exxonmobil]

Innovation and collaboration play a key role in solving today’s global challenges. Take a look at some of our groundbreaking partnerships focused on lower-emission research.

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

One-of-a-kind partners working on breakthrough innovations https://t.co/PUIyTm9lvB via @YouTube

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Growing Fuel https://t.co/4BsG2T23fc via @YouTube

[ExxonMobil @exxonmobil]

From production to combustion, here are a few reasons algae biofuel could be such a promising energy resource.

[ExxonMobil @exxonmobil]

From hours in a lab to petri dishes, find out what it takes to research the world’s next big energy source.

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

From petri dish to pond: Algae farming, in pictures - Energy Factor https://t.co/wGd3Uucyuz #EnergyFactor

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Patrick Hanks: Algae engineer - Energy Factor https://t.co/faK7Pmx3Ub #EnergyFactor

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

We’re at #AspenIdeas talking about scaling up lower-emission energy solutions at the panel ‘Technologies Needed to Meet the Dual Energy Challenge,’ hosted by our partner #ExxonMobil, VP of R&D Vijay Swarup.

[AtlanticLIVE @AtlanticLIVE]

Next an #AspenIdeas session produced by our underwriter—@exxonmobil Presents: Tech Needed to Meet the Dual Energy Challenge. @SynGenomeInc's Oliver Fetzer, @NREL's Martin Keller, @Princeton's @Loo_Group, + Vijay Swarup on meeting growing demand + lowering emissions #sponsored

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Working on tomorrow’s #biofuel with @exxonmobil - learn about our progress and what's on the horizon. https://t.co/iC7VG8tFSF via @YouTube

[ExxonMobil @exxonmobil]

From petri dish to pond to potential biofuel, watch how we are continuing our algae research in Calipatria, CA, with @SynGenomeInc.

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Syn bio poised for big impact. @biocompare talks with @SynGenomeInc on advances in syn bio for RNA therapeutics. https://t.co/TJVr4zAgMg

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Recent changes to @SynGenomeInc BoD supports our evolved company strategy and increased business focus on algal cell engineering and RNA medicines https://t.co/84lnQS33sC.

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

It's been a great decade! Thanks for the partnership @exxonmobil.

[ExxonMobil @exxonmobil]

We’ve had many proud moments on our nearly 10-year journey to convert algae to low-emission biofuel. Here are a few of our favorites. #UnexpectedEnergy

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Tailored vaccines and therapeutic medicines: Dan Gibson (aka “genome engineer”) discusses the potential of digitized biology and how it can change healthcare, via @WSJ: https://t.co/iwWn8FG0Xm

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Dan Gibson's #TEDTalk is now online! Sending vaccines like they're a fax. @TEDTalks #TED2018 https://t.co/eBwqHaz4yt

[TED Talks @TEDTalks]

How to build synthetic DNA and send it across the internet: https://t.co/LPNw2H47AD

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Congrats to our team published in @PNASNews: Successful targeting, stacking and removal of multiple redundant genes in microalgae paves the way for improved industrial production of algae-based biofuel https://t.co/Az3KHBfcGf

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Help us in welcoming industry vet Todd Nelson as CEO of @sgi_dna. Todd’s leadership will help with accelerated growth and drive spin-out from @SynGenomeInc: https://t.co/h2njdppSC5

[Viridos - formerly Synthetic Genomics @SynGenomeInc]

Congrats Jun Urano. We're so happy you're on our team! #scientistoftheday https://t.co/52CJuzy9rF

[Azenta Life Sciences @AzentaSciences]

Our Scientist of the Day is Dr. Jun Urano. Dr. Jun Urano joined SGI in 2011 and has played a key role in establishing genetic tools for engineering Cmax, such as novel DNA cassette construction methods, genome sequencing, and genome editing techniques. https://t.co/hlySsF623T